Revolution Medicines, Inc. (RVMD)
211.58
+2.12
(+1.01%)
USD |
NASDAQ |
Aug 24, 16:00
211.40
-0.18
(-0.09%)
After-Hours: 19:52
Revolution Medicines Total Assets (Quarterly) : 4.323B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.323B |
| March 31, 2026 | 2.254B |
| December 31, 2025 | 2.408B |
| September 30, 2025 | 2.252B |
| June 30, 2025 | 2.430B |
| March 31, 2025 | 2.365B |
| December 31, 2024 | 2.603B |
| September 30, 2024 | 1.763B |
| June 30, 2024 | 1.808B |
| March 31, 2024 | 1.908B |
| December 31, 2023 | 2.089B |
| September 30, 2023 | 984.23M |
| June 30, 2023 | 1.074B |
| March 31, 2023 | 1.073B |
| December 31, 2022 | 838.19M |
| September 30, 2022 | 825.91M |
| Date | Value |
|---|---|
| June 30, 2022 | 632.80M |
| March 31, 2022 | 682.77M |
| December 31, 2021 | 765.96M |
| September 30, 2021 | 734.98M |
| June 30, 2021 | 774.05M |
| March 31, 2021 | 811.65M |
| December 31, 2020 | 586.83M |
| September 30, 2020 | 595.07M |
| June 30, 2020 | 453.96M |
| March 31, 2020 | 454.34M |
| December 31, 2019 | 231.36M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 173.50M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Tango Therapeutics, Inc. | 1.074B |
| Erasca, Inc. | 435.05M |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Intellia Therapeutics, Inc. | 857.16M |
| Beam Therapeutics, Inc. | 1.386B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.717B |
| Shareholders Equity (Quarterly) | 2.606B |
| Debt to Equity Ratio | 0.4568 |
| Current Ratio | 11.38 |
| Net Debt Paydown Yield | -0.53% |